Procter & Gamble Financial Statements (PG)
|
|
|
|
Report date
|
|
|
05.08.2022 |
30.06.2023 |
04.08.2023 |
30.06.2024 |
05.08.2024 |
|
18.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
80 187 |
82 006 |
82 006 |
84 039 |
84 039 |
|
82 996 |
|
Operating Income, bln rub |
|
|
17 813 |
18 134 |
18 134 |
19 886 |
18 545 |
|
17 966 |
|
EBITDA, bln rub |
? |
|
21 241 |
21 823 |
21 771 |
22 782 |
23 844 |
|
21 205 |
|
Net profit, bln rub |
? |
|
14 742 |
14 653 |
14 653 |
14 879 |
14 879 |
|
13 987 |
|
|
OCF, bln rub |
? |
|
16 723 |
16 848 |
16 848 |
19 847 |
19 846 |
|
21 143 |
|
CAPEX, bln rub |
? |
|
3 156 |
3 062 |
3 062 |
3 322 |
3 322 |
|
3 356 |
|
FCF, bln rub |
? |
|
13 567 |
13 786 |
13 786 |
16 525 |
16 524 |
|
17 787 |
|
Dividend payout, bln rub
|
|
|
8 770 |
8 999 |
8 999 |
9 312 |
9 312 |
|
9 628 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
59.5% |
61.4% |
61.4% |
62.6% |
62.6% |
|
68.8% |
|
|
OPEX, bln rub |
|
|
20 217 |
21 112 |
21 112 |
23 305 |
24 894 |
|
24 058 |
|
Cost of production, bln rub |
|
|
42 157 |
42 760 |
42 760 |
40 848 |
40 600 |
|
40 972 |
|
R&D, bln rub |
|
|
2 000 |
0.000 |
2 000 |
0.000 |
2 000 |
|
2 000 |
|
Interest expenses, bln rub |
|
|
439.0 |
756.0 |
756.0 |
925.0 |
925.0 |
|
911.0 |
|
|
Assets, bln rub |
|
|
117 208 |
120 829 |
120 829 |
122 370 |
122 370 |
|
126 482 |
|
Net Assets, bln rub |
? |
|
46 589 |
47 065 |
46 777 |
50 559 |
50 287 |
|
51 840 |
|
Debt, bln rub |
|
|
31 493 |
34 607 |
34 607 |
32 460 |
33 369 |
|
36 153 |
|
Cash, bln rub |
|
|
7 214 |
8 246 |
8 246 |
9 482 |
9 482 |
|
12 156 |
|
Net debt, bln rub |
|
|
24 279 |
26 361 |
26 361 |
22 978 |
23 887 |
|
23 997 |
|
|
Ordinary share price, rub |
|
|
143.8 |
151.7 |
151.7 |
164.9 |
164.9 |
|
151.4 |
|
Number of ordinary shares, mln |
|
|
2 410 |
2 414 |
2 368 |
2 472 |
2 360 |
|
2 356 |
|
|
Market cap, bln rub |
|
|
346 577 |
366 301 |
359 351 |
407 666 |
389 228 |
|
356 611 |
|
EV, bln rub |
? |
|
370 856 |
392 662 |
385 712 |
430 644 |
413 115 |
|
380 608 |
|
Book value, bln rub |
|
|
-16 790 |
-17 377 |
-17 665 |
10 256 |
-12 063 |
|
-11 184 |
|
|
EPS, rub |
? |
|
6.12 |
6.07 |
6.19 |
6.02 |
6.30 |
|
5.94 |
|
FCF/share, rub |
|
|
5.63 |
5.71 |
5.82 |
6.69 |
7.00 |
|
7.55 |
|
BV/share, rub |
|
|
-6.97 |
-7.20 |
-7.46 |
4.15 |
-5.11 |
|
-4.75 |
|
|
EBITDA margin, % |
? |
|
26.5% |
26.6% |
26.5% |
27.1% |
28.4% |
|
25.5% |
|
Net margin, % |
? |
|
18.4% |
17.9% |
17.9% |
17.7% |
17.7% |
|
16.9% |
|
FCF yield, % |
? |
|
3.91% |
3.76% |
3.84% |
4.05% |
4.25% |
|
4.99% |
|
ROE, % |
? |
|
31.6% |
31.1% |
31.3% |
29.4% |
29.6% |
|
27.0% |
|
ROA, % |
? |
|
12.6% |
12.1% |
12.1% |
12.2% |
12.2% |
|
11.1% |
|
|
P/E |
? |
|
23.5 |
25.0 |
24.5 |
27.4 |
26.2 |
|
25.5 |
|
P/FCF |
|
|
25.5 |
26.6 |
26.1 |
24.7 |
23.6 |
|
20.0 |
|
P/S |
? |
|
4.32 |
4.47 |
4.38 |
4.85 |
4.63 |
|
4.30 |
|
P/BV |
? |
|
-20.6 |
-21.1 |
-20.3 |
39.7 |
-32.3 |
|
-31.9 |
|
EV/EBITDA |
? |
|
17.5 |
18.0 |
17.7 |
18.9 |
17.3 |
|
17.9 |
|
Debt/EBITDA |
|
|
1.14 |
1.21 |
1.21 |
1.01 |
1.00 |
|
1.13 |
|
|
R&D/CAPEX, % |
|
|
63.4% |
0.00% |
65.3% |
0.00% |
60.2% |
|
59.6% |
|
|
CAPEX/Revenue, % |
|
|
3.94% |
3.73% |
3.73% |
3.95% |
3.95% |
|
4.04% |
|
| Procter & Gamble shareholders |
